The State of the Art lecture at #SLDSummit turned the spotlight on MetALD and the emerging therapeutic targets identified through preclinical models. The session explored how metabolic and alcohol related liver disease converge, examining the distinct pathophysiology that shapes prognosis, diagnosis and treatment strategies. By framing MetALD as a critical category within the broader SLD spectrum, the discussion highlighted how experimental insights can inform future therapeutic development and refine clinical approaches. #SLDSummit @GSzaboMD